Deerfield Management’s Novavax NVAX Stock Holding History

Deerfield Management’s Portfolio NVAX Stock Details NVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-92,597	Closed	-$1.17M	–	314
2024 Q3	$1.17M	Buy	+92,597	New	+$1.2M	0.02%	111
2016 Q2	–	Sell	-122,813	Closed	-$12.7M	–	112
2016 Q1	$12.7M	Buy	+122,813	New	+$13.2M	0.54%	51
2015 Q4	–	Sell	-52,000	Closed	-$7.35M	–	119
2015 Q3	$7.35M	Buy	+52,000	New	+$11.7M	0.28%	76
2013 Q4	–	Sell	-53,849	Closed	-$3.39M	–	120
2013 Q3	$3.39M	Buy	+53,849	New	+$3.03M	0.16%	88

Other funds holding NVAX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SCM

Shah Capital Management Raleigh, North Carolina $521M AUM 46.95% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Sanofi Paris, France $336M AUM 126.85% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Deerfield Management's NVAX Position: Q4 2024 in Review

Deerfield Management sold out of Novavax (NVAX) in Q4 2024, closing a stake of 92,597 shares — an estimated $1.17M sold.

Deerfield Management first reported a position in NVAX in Q3 2013 and held it in 4 quarters. The position peaked at $12.7M in Q1 2016. 234 funds tracked by Wall St. Rank hold NVAX as of Q4 2024.

Deerfield Management reported no remaining Novavax position as of Q4 2024 after selling out during the quarter.
Deerfield Management sold 92,597 Novavax shares in Q4 2024, an estimated $1.17M.
Deerfield Management first reported a position in Novavax in Q3 2013 and held it in 4 quarters.
Deerfield Management's Novavax position peaked at $12.7M in Q1 2016.
234 funds tracked by Wall St. Rank held Novavax as of Q4 2024.

Based on Deerfield Management's 13F filing for Q4 2024, filed 14 Feb 2025.